DJIA 18,260.75 -24.99 -0.14%
NASDAQ 5,096.54 5.74 0.11%
S&P 500 2,129.35 -1.47 -0.07%
market minute promo

237.92 4.65 (1.99%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VRX $237.92 1.99%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $233.17
Previous Close $233.27
Daily Range $232.03 - $237.41
52-Week Range $106.00 - $237.41
Market Cap $81.5B
P/E Ratio 79.07
Dividend (Yield) $0.00 (0.0%)
Volume 305,810
Average Daily Volume 1,766,667
Current FY EPS $2.96

Sector

Healthcare

Industry

Drug Makers

Valeant Pharmaceuticals (VRX) Description

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology. Website: http://www.valeant.com/

News & Commentary Rss Feed

Meet the Company That May Become Healthcare's Version of Berkshire Hathaway

Warren Buffett's Berkshire Hathaway may be the most revered acquiring company on the planet, but one well-known hedge fund manager claims this company could be setting up its own Berkshire-like dominance in the healthcare sector.

Calithera Biosciences (CALA) in Focus, Stock Rises 10.8% - Tale of the Tape

Synergy Pharmaceuticals (SGYP) Jumps: Stock Rises 7.3% - Tale of the Tape

Valeant CEO: Healthcare Sector A 'Bit Of A Bubble'

Alibaba, Dollar General and 3 Other Stocks Big Hedge Funds Hated Last Quarter

5 Stocks the Biggest Hedge Funds Bought Last Quarter

Should You Get Rid of Aerie Pharmaceuticals (AERI) Now? - Tale of the Tape

6 stocks to buy...according to hedge funds

Endo to Acquire Par Pharma for $8.05B, Shares Down - Analyst Blog

Theravance Biopharma Posts Positive Data on Velusetrag - Analyst Blog

Theravance Biopharma Posts Positive Data on Velusetrag - Analyst Blog

Bill Ackman Adds Two Positions to Portfolio in 1QFY15

See More VRX News...

VRX's Top Competitors

VRX $237.92 (1.99%)
Current stock: VRX
JNJ $102.05 (-0.36%)
Current stock: JNJ
NVS $104.48 (-0.30%)
Current stock: NVS
RHHBY $36.95 (-0.62%)
Current stock: RHHBY